Interferon-complement loop in transplant-associated thrombotic microangiopathy

Transplant-associated thrombotic microangiopathy (TA-TMA) is an important cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). The complement inhibitor eculizumab improves TA-TMA, but not all patients respond to therapy, prompting a search for additional targetable...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Adv
Hoofdauteurs: Jodele, Sonata, Medvedovic, Mario, Luebbering, Nathan, Chen, Jenny, Dandoy, Christopher E., Laskin, Benjamin L., Davies, Stella M.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2020
Onderwerpen:
Transplantation
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7094010/
https://ncbi.nlm.nih.gov/pubmed/32208488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001515
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items